Daily Derm Times: April 18, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Retirement Plans 101: What Dermatologists Need to Know

QRPs are key to dermatologists' retirement plans—learn the benefits, drawbacks, and how to choose the best strategy for your financial goals.

Art Meets Medicine in Bold New AAD Showcase

Spearheaded by John Zampella, MD, FAAD, and Mitchell Hanson, the project highlights how art can foster community and empathy in dermatology.

FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria

Dupilumab becomes the first targeted therapy approved for chronic spontaneous urticaria in more than a decade.

Gene Expression Profile Testing Offers Clinicians a Path to Safely Avoid SLNB in Low-Risk Melanoma Patients

New prospective data from the DECIDE study reinforce the role of the 31-GEP test in clinical decision-making.

Immunocompromised Patients with Actinic Keratosis Respond Well to LED Daylight Photodynamic Combination Therapy

Solid organ transplant recipients saw a 79.6% decrease in lesions 12 weeks after the treatment sessions.

The Hidden Complexity of Reporting AEs

Trials often exclude high-risk patients, limiting the real-world relevance of their safety findings.

Treating Rosacea and Other Concerns with Generative Skin’s Ingredient Library

As a patient with rosacea herself, Anastasia Georgievskaya highlights the innovation of Generative Skin in patient education.